Detalles de la búsqueda
1.
Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue.
Biol Reprod;
108(6): 945-959, 2023 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36930063
2.
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention.
Diabetes Metab Syndr Obes;
17: 865-880, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38406269
3.
Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota.
Front Endocrinol (Lausanne);
13: 1030151, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36619569
Resultados
1 -
3
de 3
1
Próxima >
>>